• Explore /
  • Poster
  • / Phase I clinical trials in refractory colorectal cancer (CRC): Do older adult patients benefit?

Phase I clinical trials in refractory colorectal cancer (CRC): Do older adult patients benefit?

Abstract Poster

Authors

Sukeshi Arora

Sukeshi Patel Arora

UT Health San Antonio Cancer Center, San Antonio, TX

Sukeshi Patel Arora , Norma S. Ketchum , Jonathan Gelfond , Joel Michalek , Devalingam Mahalingam

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Cancers of the Colon, Rectum, and Anus

Sub Track

Multidisciplinary Treatment

Citation

J Clin Oncol 36, 2018 (suppl 4S; abstr 784)

DOI

10.1200/JCO.2018.36.4_suppl.784

Abstract #

784

Poster Bd #

L7

Abstract Disclosures

Similar Posters

Poster

2023 ASCO Gastrointestinal Cancers Symposium

Phase 1 dose-finding trial of cabozantinib (cabo) and trifluridine/tipiracil (FDT/TPI) in metastatic colorectal carcinoma (mCRC).

Phase 1 dose-finding trial of cabozantinib (cabo) and trifluridine/tipiracil (FDT/TPI) in metastatic colorectal carcinoma (mCRC).

First Author: Farshid Dayyani

First Author: Soham Ali

First Author: Reem El Khoury

First Author: Smith Giri